Zoetis director gets 1,936 RSUs grant

Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/19/2026 - 08:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. director Mark Stetter received a grant of 1,936 restricted stock units (RSUs) of Zoetis common stock. Each RSU represents the right to receive one Zoetis share and is issued at no cash cost, vesting after one year of continued service, subject to certain early-vesting events.

Insider Trade Summary

Grant/Award: 1,936 shares

Grant/Award 1 txn

Insider Stetter Mark

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	1,936	$0.00	$0.00
Holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 3,501.3011 contracts for 1,565.3011 underlying shares (Direct)

Footnotes (5)

1. F1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. F2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
3. F3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. F4. Not applicable.
5. F5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, May 21, 2025, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Zoetis (ZTS) director Mark Stetter report?

Mark Stetter reported receiving a grant of 1,936 restricted stock units (RSUs) in Zoetis Inc. common stock. These units are a form of equity compensation that convert into shares if specific vesting conditions, including continued service, are satisfied.

What does each restricted stock unit represent for Zoetis (ZTS)?

Each Zoetis RSU represents a contingent right to receive one share of Zoetis Inc. common stock. The shares are delivered only after the RSUs vest, linking director compensation to the company’s future performance and continued board service.

When will the new Zoetis (ZTS) RSUs granted to Mark Stetter vest?

The new RSUs will vest and be settled in Zoetis common stock on the first anniversary of the grant date, assuming Mark Stetter continues to serve through that vesting date, with potential earlier vesting upon certain specified events.

Are cash payments involved in the Zoetis (ZTS) RSU grant to Mark Stetter?

The RSU grant is awarded at a stated price of $0.00 per unit, meaning no cash is paid to acquire the units. Value is realized later if the RSUs vest and convert into Zoetis common shares that can then be held or sold.

Under which plan were the new Zoetis (ZTS) RSUs for Mark Stetter granted?

The RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. This plan authorizes equity-based awards such as restricted stock units and related dividend equivalents for directors, executives, and other eligible participants.

Do the Zoetis (ZTS) RSUs for Mark Stetter include dividend equivalents?

Yes. The reported RSUs include dividend equivalent units automatically issued on the underlying restricted stock units. These equivalents mirror dividends on Zoetis common stock, increasing the number of RSUs credited until vesting and settlement into actual shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stetter Mark

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	(2)	02/18/2026		A		1,936		(3)	(4)	Common Stock	1,936	$0	1,936	D
Restricted Stock Unit(1)	(2)							(5)	(4)	Common Stock	1,565.3011		1,565.3011	D

Explanation of Responses:

1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

4. Not applicable.

5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, May 21, 2025, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.